# Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715

> **NCT00365781** · PHASE1 · COMPLETED · sponsor: **Ionis Pharmaceuticals, Inc.** · enrollment: 10 (—)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** ISIS 113715

## Key facts

- **NCT ID:** NCT00365781
- **Lead sponsor:** Ionis Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 10 (—)
- **Last updated:** 2007-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00365781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00365781, "Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00365781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*